by Staff

Udall logo by Peter Brown

Original Articles
  1. Mattis PJ, Tang CC, Ma Y, Dhawan V, Eidelberg D. Network correlates of the cognitive response to levodopa in Parkinson’s disease. Neurology 2011; 77:858-65. [PMC 3162641]
  2. Dhawan V, Tang CC, Ma Y, Spetsieris P, Eidelberg D. Abnormal network topographies and changes in global activity: Absence of a causal relationship. NeuroImage 2012; 63(4):1827-32. [PMC 3474325]
  3. Ma Y, Peng S, Spetsieris PG, Sossi V, Eidelberg D, Doudet DJ. Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism. J Cereb Blood Flow Metab 2012; 32: 633-42. [PMC 3318142]
  4. Mure H, Tang CC, Argyelan M, Ghilardi MF, Kaplitt MG, Dhawan V, Eidelberg D. Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation. J Neurosci 2012; 32(8):2804-13. [PMC 4557784]
  5. Ohlin KE, Fancardo V, Lindgren HS, Sillivan SE, O’Sullivan SS, Luksik AS, Vassoler FM, Lees AJ, Konradi C, Cenci MA. Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia. Brain 2011; 134(pt8): 2339-57. [PMC 3155708]
  6. Ohlin KE, Sebastianutto I, Adkins CE, Lundblad C, Lockman PR, Cenci MA. Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson’s disease. NeuroImage 2012; 61(1):228-39. [**Selected as “Article of the Month” at Lund Medical Faculty]. [PMC 4455552]
  7. Poston KL, Tang CC, Eckert T, Dhawan V, Frucht S, Vonsattel JP, Fahn S, Eidelberg D. Network correlates of disease severity in multiple system atrophy. Neurology 2012; 78(16): 1237-44. [PMC 3324319]
  8. Ko JH, Mure H, Tang CC, Ma Yilong, Dhawan V, Spetsieris PG, Eidelberg D. Parkinson’s disease: Increased motor network activity in the absence of movement.J Neurosci 2013; 33(10): 4540-9 [PMC 3671574]
  9. Niethammer M, Tang CC, Ma Y, Mattis PJ, Ko JH, Dhawan V, Eidelberg D. Parkinson’s disease cognitive network correlates with caudate dopamine. NeuroImage 2013; 78C: 204-9 [PMC 3672243]
  10. Spetsieris P, Ma Y, Peng S, Ko JH, Dhawan V, Tang CC, Eidelberg D. Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data Journal of Visualized Experiments, 2013; 76: e5031
    [You can watch the video of this article below. If you’re using Firefox, though, please try viewing it on another browser; we’re trying to fix the problem as soon as possible. If your institution subscribes to J Vis Exp, you can also click on the following link:]
  11. Moustafa AA, Herzallah MM, Gluck MA. Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson’s disease. Neurodegenerative Disease 2013; 11(2):102-11. [PMC 3728991]
  12. Ko JH, Spetsieris PG, Mattis P, Feigin A, Dhawan V, Eidelberg, D. Quantifying significance of topographic similarities of disease-related brain metabolic patterns. PLoS One 2014; 9(1): e88119. [PMC 3909315]
  13. Robeson W, Dhawan V, Ma Y, Bjelke D, Margouleff C, Chaly T, Eidelberg D. Radiation absorbed dose to the basal ganglia from dopamine transporter radioligand [18F]-FPCIT. Biomed Res Int 2014; 2014:Article ID 498072. [PMC 4100344]
  14. Holtbernd F, Gagnon JF, Postuma RB, Ma Y, Tang CC, Feigin A, Dhawan V, Vendette M, Soucy JP, Eidelberg D, Montplaisir J. Abnormal metabolic network activity in REM sleep behavior disorder. Neurology 2014; 82(7): 620-7. [PMC 3963420]
  15. Peng S, Ma Y, Spetsieris PG, Mattis P, Feigin A, Dhawan V, Eidelberg D. Characterization of disease-related covariance topographies with SSM/PCA toolbox: Effects of spatial normalization and PET scanners. Hum Brain Mapp 2014; 35(5): 1801-14. [PMC 3778048]
  16. Ko JH, Feigin A, Mattis PJ, Tang CC, Ma Y, Dhawan V, During MJ, Kaplitt MG, Eidelberg D. Network modulation following sham surgery in Parkinson’s disease. J Clin Invest 2014; 124(8): 3656-66. [PMC 4109544]
  17. Niethammer M, Tang CC, Feigin A, Allen PJ, Heinen L, Hellwig S, Amtage F, Hanspal E, Vonsattel JP, Poston KL, Meyer PT, Leenders KL, Eidelberg D. A disease-specific metabolic brain network associated with corticobasal degeneration. Brain 2014; 137(11):3036-68. [PMC 4208467]
  18. Wu P, Yu H, Peng S, Dauvilliers Y, Wang J, Ge J, Zhang H, Eidelberg D, Ma Y, Zuo C. Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behavior disorder. Brain 2014; 137(pt12): 3122-8. [PMC 4240297]
  19. Tomer R, Slagter HA, Christian BT, Fox AS, King CR, Murali D, Gluck MA, Davidson RJ. Love to win or hate to lose? Asymmetry of dopamine D2 receptor binding predicts sensitivity to reward vs. punishment. J Cogn Neurosci 2014; 26(5):1039-48. [PMC 3972269]
  20. Spetsieris PG, Ko JH, Tang CC, Nazem A, Sako W, Peng S, Ma Y, Dhawan V, Eidelberg D. Metabolic resting-state networks in health and disease. Proc Natl Acad Sci USA 2015; 112(8): 2563-68. [PMC 4345616]
  21. Ko JH, Lerner RP, Eidelberg D. Effects of levodopa on regional cerebral metabolism and blood flow. Mov Disord 2015; 30(1): 54-63. [PMC 4314428]
  22. Ma Y, Johnston TH, Peng S, Zuo C, Koprich JB, Fox SH, Ghan Y, Eidelberg D, Brotchie JM. Reproducibility of a parkinsonism-related metabolic brain network in nonhuman primates: A descriptive pilot study with FDG PET. Mov Disord 2015; 30(9):1283-8. [PMC 4574308]
  23. Wu T, Ma Y, Zheng Z, Peng S, Wu X, Eidelberg D, Chan P. Parkinson’s disease-spatial covariance pattern identified with resting-state functional MRI. J Cereb Blood Flow Metab 2015; 35:1764-70. [PMC 4635231]
  24. Ge J, Wu P, Peng S, Yu H, Zhang H, Guan Y, Eidelberg D, Zuo C, Ma Y, Wang J. Assessing cerebral glucose metabolism in patients with idiopathic rapid eye movement sleep behavior disorder. J Cereb Blood Flow Metab2015; 35:2062-9. [PMC 4635250]
  25. Meles SK, Tang CC, Teune LK, Dierckz RA, Dhawan V, Mattis PJ, Leenders KL, Eidelberg D. Abnormal metabolic pattern associated with cognitive impairment in Parkinson’s disease: A validation study. J Cereb Blood Flow Metab 2015; 35(9):1478-84. [PMC 4640325]
  26. Holtbernd F, Ma Y, Peng S, Schwartz F, Timmerman L, Kracht L, Fink GR, Tang CC, Eidelberg D, Eggers C. Dopaminergic correlates of metabolic activity in Parkinson’s disease. Hum Brain Mapp 2015; 36(9):3575-85.
  27. Tripathi M, Tang CC, Feigin A, DeLucia I, Nazem A, Dhawan V, Eidelberg D. Automated differential diagnosis of early parkinsonism using metabolic brain networks: A validation study. J Nucl Med 2016; 57(1): 60-6. [PMC: in process]
Chapters, Reviews, and Editorials
    1. Poston KL, Eidelberg D. Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage 2012; 62(4): 2261-70. [PMC 3489159] [Review]
    2. Holtbernd F, Eidelberg D. Functional brain networks in movement disorders: Recent advances. Curr Opin Neurol 2012; 25(4):392-401. [PMC 4554600] [Review]
    3. Niethammer M, Feigin A, Eidelberg D. Functional neuroimaging in Parkinson’s disease. Cold Spring Harb Perspect Med 2012; 2(5): a009274. [PMC 3331691] [Review]
    4. Niethammer M, Eidelberg D. Metabolic brain networks in translational neurology: concepts and applications. Ann Neurol 2012; 72(5):635-47. [PMC 4564117] [Review]
    5. Perlmutter JS, Eidelberg D. To scan or not to scan: DaT is the question. Neurology 2012; 78: 688-9. [Editorial]
    6. Simon JR, Gluck MA. Adult age differences in learning and generalization of feedback-based associations. Psych Aging 2013; 937-47. [Review]
    7. Holtbernd F, Eidelberg D. The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes. Semin Neurol 2014; 34(2): 823-37. [Review] [PMC 4556352]
    8. Peng S, Eidelberg D, Ma Y. Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease. Neurosci Bull 2014; 30(5):823-37 [Review] [PMC 4556355]
    9. Allen PJ, Feigin A. Gene-based therapies in Parkinson’s disease. Neurotherapeutics 2014; 11(1):60-7. [Review] [PMC 3899481]